GovChime
Notice ID: 3c84f292afa641e087c796b8536f5703Presolicitation

Cancer Screening Follow up

Archived on August 22, 2020. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM UTC−04:00
Posted
July 23, 2020
Notice type
Presolicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH National Cancer Institute
Last updated
Apr 29, 2026

Identifiers

Solicitation number
75N91020R00033
Notice ID
3c84f292afa641e087c796b8536f5703

Description

Note: This synopsis follows a Small Business Sources Sought notice that was released on May 07, 2020 under NIH-NCI-SBSS-ETSB-00033. THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR PROPOSAL. A SOLICITATION WILL BE ISSUED ON A LATER DATE. Title: Cervical Cancer Screening Follow Up Description: The National Cancer Institute (NCI) has funded previous studies conducted at Kaiser Permanente Northern California to collect biospecimens for biomarker testing and to study risk estimates for cervical cancer screening. The NCI acquired detailed clinical and risk factor history and follow-up data for over 100,000 women enrolled in previous studies with Kaiser Permanente Northern California (KPNC). In addition, the NCI has analyzed similar data for over 1.5 million women screened for cervical cancer at KPNC clinics. Despite Human Papillomavirus (HPV) vaccines, screening will remain central for decades to control cervical cancer. Recently, HPV testing alone or with cytology was introduced in the US as an alternative to cytology screening. However, most HPV infections are harmless and additional tests are required to identify women at highest cancer risk. Purpose and Objectives: The purpose of this requirement is to acquire follow-up, de-identified, clinical data from participants in the KPNC studies. The Contractor shall provide the results of all HPV and cytology-based testing as well as all colposcopy, biopsy and treatment procedures, as well as relevant co-factor data, within the screening program for women at KPNC. The data sets are based on evaluations and analysis made over the course of a year. For each phase there is one data set. The total number of data sets anticipated is five. Specific tasks to be performed by the Contractor include the following: The Contractor shall use existing laboratory and clinical datasets within the KPNC integrated health services delivery system to deliver the following data to NCI: age at visits, STD information (chlamydia, HIV, gonorrhea), hormonal contraception use, smoking status, BMI, and entire history of HPV, Pap results, and all coded cervix histology results (from biopsy, excisional procedures or hysterectomy), previous and future enrollment status. Cervix histology results not previously coded shall be coded prior to delivery of the dataset. Period of Performance The Government anticipates one award will be made for a one (1) year base period and four (4) 12-month options as follows: Base Period: 03/01/2021 02/28/2022 Option Period One (1): 03/01/2022 02/28/2023 Option Period Two (2): 03/01/2023 02/29/2024 Option Period Three (3): 03/01/2024 02/28/2025 Option Period Four (4): 03/01/2025 02/28/2026 This acquisition will be competed through Sole Source. If a vendor is capable of performing the specified work above, please contact the point of contacted listed below. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile will be accepted. Contracting Office Address: 9609 Medical Center Drive Bethesda, Maryland 20852 Primary Point of Contact: Ogochukwu Nwankwo Contract Specialist Ogochukwu.nwankwo@nih.gov Phone: (240) 276-7504 Secondary Point of Contact: Rukshani Levy Contracting Officer & Team Lead Rukshani.levy@nih.gov Phone: (240) 276-5425

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N91020R00033
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentJul 23, 2020

    Cancer Screening Follow up

    Notice 3c84f292afa641e087c796b8536f5703 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N91020R00033

Archive Date

Aug 22, 2020

Office Address

Rockville, MD, 20850